Study on Safety, Tolerability and Prelimenary Efficacy of LNA043 in Patients Undergoing Autologous Chondrocyte Implantation
Clinical trial NCT03334812 · TERMINATED
Trial details
- NCT number
- NCT03334812
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-18
- Primary completion
- 2019-04-05
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.